| 发明名称 |
TCL1 Expression in Chronic Lymphocytic Leukemia (CLL) Regulated by MIR-29 and MIR-181 |
| 摘要 |
The present invention provides novel methods and compositions for the diagnosis, prognosis and treatment of chronic lymphocytic leukemia (CLL). The invention also provides methods of identifying anti-CLL agents.
|
| 申请公布号 |
US2010004322(A1) |
申请公布日期 |
2010.01.07 |
| 申请号 |
US20070442018 |
申请日期 |
2007.09.17 |
| 申请人 |
THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION |
发明人 |
CROCE CARLO M. |
| 分类号 |
A61K31/7105;C12Q1/68;C40B30/04 |
主分类号 |
A61K31/7105 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
